BioXcel Therapeutics (BTAI) Leases (2022 - 2025)
Historic Leases for BioXcel Therapeutics (BTAI) over the last 4 years, with Q3 2025 value amounting to $140000.0.
- BioXcel Therapeutics' Leases fell 6963.12% to $140000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $140000.0, marking a year-over-year decrease of 6963.12%. This contributed to the annual value of $382000.0 for FY2024, which is 4447.67% down from last year.
- As of Q3 2025, BioXcel Therapeutics' Leases stood at $140000.0, which was down 6963.12% from $222000.0 recorded in Q2 2025.
- In the past 5 years, BioXcel Therapeutics' Leases registered a high of $1.2 million during Q1 2022, and its lowest value of $140000.0 during Q3 2025.
- Moreover, its 4-year median value for Leases was $688000.0 (2023), whereas its average is $677666.7.
- In the last 5 years, BioXcel Therapeutics' Leases plummeted by 2328.54% in 2023 and then crashed by 6963.12% in 2025.
- Quarter analysis of 4 years shows BioXcel Therapeutics' Leases stood at $976000.0 in 2022, then dropped by 29.51% to $688000.0 in 2023, then crashed by 44.48% to $382000.0 in 2024, then plummeted by 63.35% to $140000.0 in 2025.
- Its last three reported values are $140000.0 in Q3 2025, $222000.0 for Q2 2025, and $303000.0 during Q1 2025.